This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Fritiof Pontėn: Innovator in Cardiac Arrhythmia Treatment
Introduction
Fritiof Pontėn is a notable inventor based in Askim, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac arrhythmias. His innovative work has led to the development of valuable compounds that can aid in the management of heart conditions.
Latest Patents
Fritiof Pontėn holds a patent for "Oxabispidine compounds useful in the treatment of cardiac arrhythmias." This patent describes compounds of formula I, wherein R, R, R, R, R to R, A, B, and G have specific meanings provided in the description. These compounds are particularly useful in the prophylaxis and treatment of arrhythmias, especially atrial and ventricular arrhythmias. He has 1 patent to his name.
Career Highlights
Fritiof Pontėn is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions for complex health issues, particularly in cardiology.
Collaborations
Fritiof has collaborated with talented colleagues such as Annika Björe and Magnus Björsne. Their combined expertise has contributed to advancements in the field of cardiac treatment.
Conclusion
Fritiof Pontėn's contributions to the treatment of cardiac arrhythmias through his innovative compounds highlight his role as a significant inventor in the medical field. His work continues to impact the lives of many patients suffering from heart conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile